Zhang X Z, Imachi H, Lyu J Y, Fukunaga K, Sato S, Ibata T, Kobayashi T, Yoshimoto T, Kikuchi F, Dong T, Murao K
Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1, ikenobe, Miki-CHO, 761-0793, Kagawa, Japan.
J Endocrinol Invest. 2017 Apr;40(4):437-445. doi: 10.1007/s40618-016-0589-3. Epub 2016 Dec 2.
Prolactin regulatory element-binding protein (PREB), a member of the WD-repeat protein family, has been recognized as a transcriptional factor that regulates prolactin promoter activity in the anterior pituitary of rats. PREB is expressed not only in the pituitary but also in various other tissues, including the adipose tissue. Previous studies have shown that PREB acts as a transcriptional regulator and suppresses the expression of the adiponectin gene in cultured 3T3L1 preadipocytes. The aim of this study was to further examine the potential role of PREB in adipose tissue in vivo.
Transgenic mice that overexpressing PREB (PREB transgenic mice) were generated. Insulin resistance was evaluated in PREB transgenic mice using glucose and insulin tolerance tests. Adiponectin expression in the adipose tissue was examined by western blot analysis and quantitative polymerase chain reaction (qPCR). The expression levels of stearoyl-CoA desaturase (Scd) and adiponectin receptor 2(ADIPOR2) were quantified by qPCR.
Glucose and insulin tolerance tests revealed insulin resistance in PREB transgenic mice. Serum adiponectin and leptin concentrations were decreased. Adiponectin gene expression was decreased in the adipose tissue, which was confirmed by the downregulation of the adiponectin-dependent hepatic Scd gene and upregulation of the ADIPOR2 gene in the liver of PREB transgenic mice. We also found that pioglitazone, an agonist for the peroxisome proliferator-activated receptor-r, improved the insulin resistance in the PREB transgenic mice after a 10-day feeding period.
These results demonstrated that PREB might contribute to the regulation of adiponectin gene expression in vivo.
催乳素调节元件结合蛋白(PREB)是WD重复蛋白家族的成员,已被确认为一种转录因子,可调节大鼠垂体前叶中催乳素启动子的活性。PREB不仅在垂体中表达,还在包括脂肪组织在内的各种其他组织中表达。先前的研究表明,PREB作为一种转录调节因子,可抑制培养的3T3L1前脂肪细胞中脂联素基因的表达。本研究的目的是进一步研究PREB在体内脂肪组织中的潜在作用。
构建了过表达PREB的转基因小鼠(PREB转基因小鼠)。通过葡萄糖和胰岛素耐量试验评估PREB转基因小鼠的胰岛素抵抗。通过蛋白质印迹分析和定量聚合酶链反应(qPCR)检测脂肪组织中脂联素的表达。通过qPCR定量硬脂酰辅酶A去饱和酶(Scd)和脂联素受体2(ADIPOR2)的表达水平。
葡萄糖和胰岛素耐量试验显示PREB转基因小鼠存在胰岛素抵抗。血清脂联素和瘦素浓度降低。脂肪组织中脂联素基因表达降低,这在PREB转基因小鼠肝脏中脂联素依赖性肝Scd基因的下调和ADIPOR2基因的上调中得到证实。我们还发现,过氧化物酶体增殖物激活受体-r激动剂吡格列酮在喂养10天后改善了PREB转基因小鼠的胰岛素抵抗。
这些结果表明,PREB可能在体内参与脂联素基因表达的调节。